NCT03892421 2021-05-18Outpatient Administration of R-DHAP in Relapsed/Refractory Non-Hodgkin LymphomaLa Raza Medical CenterPhase 1/2 Completed22 enrolled
NCT02408042 2017-06-27Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)Western Regional Medical CenterPhase 1/2 Withdrawn
NCT00601718 2017-05-25Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell LymphomaUniversity of WashingtonPhase 1/2 Completed29 enrolled 10 charts
NCT00003406 2013-03-26Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerNational Cancer Institute (NCI)Phase 1/2 Completed30 enrolled